Nifty Pharma

Nifty Pharma logo

Nifty Pharma Index captures the performance of the pharmaceutical sector. The Index comprises of 20 companies listed on National Stock Exchange of India (NSE).

Nifty Pharma Index is computed using free float market capitalization method, wherein the level of the index reflects the total free float market value of all the stocks in the index relative to particular base market capitalization value. Nifty Pharma Index can be used for a variety of purposes such as benchmarking fund portfolios, launching of index funds, ETFs and structured products.

          

Nifty Pharma Constituents

Price22,543.25 -295.10 (-1.29%)52 Week High24,744.25
ISININE358A0101452 Week Low17,481.80
IndustryPharmaceuticals: MajorVolume9,333
SectorHealth TechnologyP/E Ratio TTM46.33
Market Cap485.4 B1 Year Beta-0.12
Technical Rating of
Abbott India Limited (ABBOTINDIA) is a subsidiary of Abbott Laboratories, a global healthcare company headquartered in Abbott Park, Illinois, United States. Abbott India is headquartered in Gurgaon, Haryana, and has a presence in over 50 cities across India. ABBOTINDIA is a leading provider of healthcare products and services in India. The company’s products and services more about Abbott India Limited (ABBOTINDIA)

Price3,550.65 -101.20 (-2.77%)52 Week High4,243.00
ISININE540L0101452 Week Low2,940.05
IndustryPharmaceuticals: MajorVolume267.5 T
SectorHealth TechnologyP/E Ratio TTM37.13
Market Cap436.6 B1 Year Beta0.41
Technical Rating of
Alkem Laboratories Limited (ALKEM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of bulk drugs. Alkem has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Alkem is more about Alkem Laboratories Limited (ALKEM)

Price866.40 -10.05 (-1.15%)52 Week High907.70
ISININE406A0103752 Week Low397.20
IndustryPharmaceuticals: OtherVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM25.67
Market Cap513.3 B1 Year Beta0.66
Technical Rating of
Aurobindo Pharma Limited (AUROPHARMA) is an Indian multinational pharmaceutical company headquartered in Hyderabad, India. It was founded in 1986 by P. V. Ramana Rao. Aurobindo’s initial focus was on the manufacturing of generic pharmaceuticals. It has since expanded its operations to include a wide range of products, including APIs, finished dosages, and biosimilars. Aurobindo is more about Aurobindo Pharma Limited (AUROPHARMA)

Price264.35 -2.65 (-0.99%)52 Week High299.15
ISININE376G0101352 Week Low191.55
IndustryPharmaceuticals: MajorVolume3.6 M
SectorHealth TechnologyP/E Ratio TTM75.62
Market Cap320.6 B1 Year Beta1.27
Technical Rating of
Biocon Limited (BIOCON) is an Indian biopharmaceutical company headquartered in Bangalore, Karnataka, India. The company was founded in 1978 by Kiran Mazumdar-Shaw. BIOCON is a leading manufacturer of biosimilars, insulin analogs, and biopharmaceutical products. The company’s products are used in a variety of therapeutic areas, including oncology, diabetes, and cardiovascular diseases. BIOCON is a well-managed more about Biocon Limited (BIOCON)

Price1,185.90 -20.50 (-1.70%)52 Week High1,277.90
ISININE059A0102652 Week Low852.00
IndustryPharmaceuticals: OtherVolume2.8 M
SectorHealth TechnologyP/E Ratio TTM30.77
Market Cap974.5 B1 Year Beta0.06
Technical Rating of
Cipla Limited (CIPLA) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was founded in 1935 by Khwaja Abdul Hamied. CIPLA is one of the largest pharmaceutical companies in India and has a global presence, with operations in over 150 countries. The company’s products include generic drugs, branded drugs, and over-the-counter (OTC) products. more about Cipla Limited (CIPLA)

Price3,705.05 -41.75 (-1.11%)52 Week High3,934.70
ISININE361B0102452 Week Low2,730.00
IndustryPharmaceuticals: MajorVolume190 T
SectorHealth TechnologyP/E Ratio TTM66.58
Market Cap994 B1 Year Beta-0.06
Technical Rating of
Divis Laboratories Limited (DIVISLAB) is an Indian company that was founded in 1990. It is headquartered in Hyderabad, Telangana, India. DIVISLAB is a leading manufacturer of active pharmaceutical ingredients (APIs) in India. The company’s products are used in a variety of medicines, including antibiotics, anti-inflammatories, and anti-diabetics. DIVISLAB is a well-managed and profitable organization. It more about Divis Laboratories Limited (DIVISLAB)

Price5,517.05 -151.45 (-2.67%)52 Week High5,989.70
ISININE089A0102352 Week Low4,089.30
IndustryPharmaceuticals: MajorVolume489.6 T
SectorHealth TechnologyP/E Ratio TTM19.45
Market Cap943.8 B1 Year Beta0.21
Technical Rating of
Dr. Reddy’s Laboratories Limited (DRREDDY) is a pharmaceutical company headquartered in Hyderabad, Telangana, India. It was founded in 1984 and is one of the largest pharmaceutical companies in India. DRREDDY has a presence in over 100 countries and sells its products in over 65 countries. The company’s products include a wide range of generic drugs, more about Dr. Reddys Laboratories Limited (DRREDDY)

Price1,693.20 -1.65 (-0.10%)52 Week High2,238.00
ISININE068V0102352 Week Low861.00
IndustryPharmaceuticals: MajorVolume170.2 T
SectorHealth TechnologyP/E Ratio TTM37.38
Market Cap279 B1 Year Beta0.04
Technical Rating of
Gland Pharma Limited (GLAND) is an Indian company that was incorporated in 1978 and is headquartered in Hyderabad, India. GLAND is a well-established company with a strong track record. The company is a leading manufacturer of injectable pharmaceutical products in India. GLAND’s products are used in a variety of therapeutic areas, including oncology, immunology, and more about Gland Pharma Limited (GLAND)

Price1,560.55 4.75 (0.31%)52 Week High1,624.00
ISININE159A0101652 Week Low1,227.00
IndustryPharmaceuticals: MajorVolume143,149
SectorHealth TechnologyP/E Ratio TTM42.39
Market Cap263.2 B1 Year Beta0.13
Technical Rating of
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is an Indian company that was incorporated in 1978 and is headquartered in Mumbai, India. GLAXO is a well-established company with a strong track record. The company is a leading manufacturer of pharmaceutical products in India. GLAXO’s products are used in a variety of therapeutic areas, including oncology, immunology, and cardiovascular more about GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Price802.80 -24.90 (-3.01%)52 Week High880.00
ISININE935A0103552 Week Low363.65
IndustryPharmaceuticals: MajorVolume6.4 M
SectorHealth TechnologyP/E Ratio TTM88.95
Market Cap233.6 B1 Year Beta1.25
Technical Rating of
Glenmark Pharmaceuticals Limited (GLENMARK) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1977 by Gracias Saldanha. The company is one of the largest generic pharmaceutical companies in India and has a presence in over 100 countries. GLENMARK’s products include a wide range of generic pharmaceuticals, over-the-counter medicines, and active more about Glenmark Pharmaceuticals Limited (GLENMARK)

Price336.80 13.60 (4.21%)52 Week High381.00
ISININE101D0102052 Week Low267.75
IndustryPharmaceuticals: OtherVolume3.8 M
SectorHealth TechnologyP/E Ratio TTM18.89
Market Cap78.2 B1 Year Beta0.79
Technical Rating of
Granules India Limited (GRANULES) is a well-established company with a strong track record in the Indian pharmaceutical industry. The company is a leading manufacturer of active pharmaceutical ingredients (APIs) and finished dosages in India. GRANULES has a strong customer base in the Indian and global pharmaceutical markets. GRANULES is well-positioned to capitalize on the growing more about Granules India Limited (GRANULES)

Price894.25 -5.80 (-0.64%)52 Week High955.00
ISININE571A0103852 Week Low669.80
IndustryPharmaceuticals: MajorVolume474.1 T
SectorHealth TechnologyP/E Ratio TTM46.20
Market Cap228 B1 Year Beta-0.16
Technical Rating of
IPCA Laboratories Limited (IPCALAB) is an Indian pharmaceutical company that develops, manufactures, and markets generic and branded formulations. It was founded in 1974 and is headquartered in Ahmedabad, India. IPCALAB is one of the leading pharmaceutical companies in India. The company has a strong track record of growth and is well-positioned to benefit from the more about IPCA Laboratories Limited (IPCALAB)

Price386.60 -4.10 (-1.05%)52 Week High533.50
ISININE947Q0102852 Week Low278.85
IndustryPharmaceuticals: MajorVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM36.98
Market Cap210.4 B1 Year Beta0.37
Technical Rating of
Laurus Labs Limited (LAURUSLABS) is an Indian pharmaceutical company headquartered in Hyderabad, Telangana. It was founded in 2001 by Mr. Y. K. Hamied. LAURUS LABS is one of the leading pharmaceutical companies in India. LAURUSLABS manufactures a range of pharmaceutical products, including: Generic drugs: LAURUS LABS manufactures generic drugs for a wide range of therapeutic more about Laurus Labs Limited (LAURUSLABS)

Price1,097.45 -29.85 (-2.65%)52 Week High1,174.50
ISININE326A0103752 Week Low628.00
IndustryPharmaceuticals: OtherVolume1.3 M
SectorHealth TechnologyP/E Ratio TTM51.59
Market Cap513.9 B1 Year Beta0.46
Technical Rating of
Lupin Limited (LUPIN) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1968 by Mr. Desh Bandhu Gupta. LUPIN is one of the largest pharmaceutical companies in India, with a market capitalization of over $20 billion. The company manufactures a wide range of generic and branded pharmaceutical products, including anti-infectives, more about Lupin Limited (LUPIN)

Price849.15 -10.80 (-1.26%)52 Week High928.00
ISININE987B0102652 Week Low502.00
IndustryPharmaceuticals: MajorVolume445.9 T
SectorHealth TechnologyP/E Ratio TTM18.91
Market Cap153.9 B1 Year Beta0.44
Technical Rating of
Natco Pharma Limited (NATCOPHARM) is a pharmaceutical company based in Hyderabad, Telangana, India. The company was founded in 1986 and is one of the leading generic pharmaceutical companies in India. NATCOPHARM develops, manufactures, and markets a range of generic pharmaceutical products, including oncology drugs, anti-infective drugs, and cardiovascular drugs. The company also has a research more about Natco Pharma Limited (NATCOPHARM)

Price3,857.95 26.05 (0.68%)52 Week High4,660.00
ISININE182A0101852 Week Low3,408.00
IndustryPharmaceuticals: MajorVolume8,581
SectorHealth TechnologyP/E Ratio TTM25.77
Market Cap175.6 B1 Year Beta0.39
Technical Rating of
Pfizer Limited (PFIZER), India’s leading pharmaceutical company, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. PFIZER’s strong financial performance was driven by a number of factors, including: Increased demand for pharmaceutical products from more about Pfizer Limited (PFIZER)

Price7,106.65 -41.70 (-0.58%)52 Week High7,590.00
ISININE058A0101052 Week Low5,202.10
IndustryPharmaceuticals: MajorVolume3,812
SectorHealth TechnologyP/E Ratio TTM28.46
Market Cap164.6 B1 Year Beta0.28
Technical Rating of
Sanofi India Limited (SANOFI) is an Indian multinational pharmaceutical company headquartered in Gurugram, Haryana, India. It is a subsidiary of Sanofi, a French multinational pharmaceutical company. Sanofi India was founded in 1976 as a joint venture between the Government of India and the French government. The company started out as a manufacturer of vaccines. Over more about Sanofi India Limited (SANOFI)

Price1,132.35 -13.80 (-1.20%)52 Week High1,169.70
ISININE044A0103652 Week Low892.05
IndustryPharmaceuticals: MajorVolume1.6 M
SectorHealth TechnologyP/E Ratio TTM32.21
Market Cap2.7 T1 Year Beta0.29
Technical Rating of
Sun Pharmaceutical Industries Limited (SUNPHARMA) is a leading pharmaceutical company in India. The company was founded in 1983 and is headquartered in Mumbai, India. SUNPHARMA is engaged in the development, manufacturing, and marketing of generic and branded pharmaceuticals, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). In the financial year 2022-23, SUNPHARMA reported a total more about Sun Pharmaceutical Industries Limited (SUNPHARMA)

Price1,850.40 -24.00 (-1.28%)52 Week High2,094.55
ISININE685A0102852 Week Low1,445.55
IndustryPharmaceuticals: MajorVolume498.7 T
SectorHealth TechnologyP/E Ratio TTM49.70
Market Cap634.5 B1 Year Beta0.30
Technical Rating of
Torrent Pharmaceuticals Limited (TORNTPHARM) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company was founded in 1954 and is one of the leading pharmaceutical companies in India. TORNTPHARM manufactures a wide range of pharmaceutical products, including: Prescription drugs: TORNTPHARM manufactures a range of prescription drugs, such as anti-infectives, anti-diabetics, and cardiovascular more about Torrent Pharmaceuticals Limited (TORNTPHARM)

Price595.60 -20.05 (-3.26%)52 Week High668.75
ISININE010B0102752 Week Low350.25
IndustryPharmaceuticals: MajorVolume1.6 M
SectorHealth TechnologyP/E Ratio TTM23.84
Market Cap623.1 B1 Year Beta0.36
Technical Rating of
Zydus Lifesciences Limited (ZYDUSLIFE), a leading Indian pharmaceutical company, today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 1,000 million, compared to a net profit of INR 500 million in the previous year. The company’s strong financial more about Zydus Lifesciences Limited (ZYDUSLIFE)

Nifty Pharma Methodolgy

Eligibility Criteria for Selection of Constituent Stocks:
i. Companies should form part of Nifty 500 at the time of review. In case, the number of eligible stocks representing a particular sector within Nifty 500 falls below 20, then deficit number of stocks shall be selected from the universe of stocks ranked within top 800 based on both average daily turnover and average daily full market capitalisation based on previous six months period data used for index rebalancing of Nifty 500.
ii. Companies should form a part of pharmaceutical sector.
iii. The company's trading frequency should be at least 90% in the last six months.
iv. The company should have a listing history of 6 months. A company, which comes out with an IPO will be eligible for inclusion in the index, if it fulfills the normal eligibility criteria for the index for a 3 month period instead of a 6 month period.
v. Final selection of 20 companies shall be done based on the free-float market capitalization of the companies.A preference shall be given to companies that are available for trading in NSE’s Futures & Options segment at the time of final selection.
vi. Weightage of each stock in the index is calculated based on its free-float market capitalization such that no single stock shall be more than 33% and weightage of top 3 stocks cumulatively shall not be more than 62% at the time of rebalancing.
Index Re-Balancing:
Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year, i.e. For semi-annual review of indices, average data for six months ending the cut-off date is considered. Four weeks prior notice is given to market from the date of change.
Index Governance:
A professional team manages all NSE indices. There is a three-tier governance structure comprising the Board of Directors of NSE Indices Limited, the Index Advisory Committee (Equity) and the Index Maintenance Sub-Committee.

Related Indices to Nifty Pharma

The Nifty Auto Index is designed to reflect the behaviour and performance of the Indian automobiles sector. The Nifty Auto Index is computed using free float market capitalization method with a base date of January 1, 2004 indexed to a base value of 1000. more about Nifty Auto

Nifty Bank Index is comprised of the most liquid and large capitalised Indian Banking stocks. It provides investors and market intermediaries with a benchmark that captures the capital market performance of Indian Banks. more about Nifty Bank

The Nifty Financial Services Index is designed to reflect the behaviour and performance of the Indian financial market which includes banks, financial institutions, housing finance, insurance companies and other financial services companies. more about Nifty Financial Services

The Nifty Financial Services 25/50 Index comprises of same constituents as Nifty Financial Services Index, where 25 refers to the maximum value for the % weight of a single stock and 50 refers to maximum value for the aggregate % weight for all stocks with individual weight more than 5%. more about Nifty Financial Services 25/50

The Nifty Financial Services Ex Bank Index which aims to track the performance of portfolio of stocks from the Financial Services sector other than Banks. Stocks from eligible basic industries are chosen based on 6 month average free-float market capitalization. Index stock weights are based on their free-float market capitalization. more about Nifty Financial Services Ex Bank

The Nifty FMCG Index is designed to reflect the behavior of FMCGs Indian companies from (Fast Moving Consumer Goods) (FMCG) sector. It incudes companies that deals with those goods and products, which are non-durable, mass consumption products and available off the shelf. more about Nifty FMCG

The Nifty Healthcare Index is designed to reflect the behaviour and performance of the Healthcare companies. The Nifty Healthcare Index comprises of maximum of 20 stocks that are listed on the National Stock Exchange. more about Nifty Healthcare

Information Technology (IT) industry has played a major role in the Indian economy. In order to have a good benchmark of the Indian IT sector, Nifty IT sector index has been developed. Nifty IT provides investors and market intermediaries with an appropriate benchmark that captures the performance of the IT segment of the market in India. more about Nifty IT

The Nifty Media Index is designed to reflect the behavior and performance of the Media & Entertainment sector including printing and publishing in India. more about Nifty Media

The Nifty Metal Index is designed to reflect the behavior and performance of the metals sector including mining in India. more about Nifty Metal

The Nifty Private Bank Index is designed to reflect the performance of the banks from private sector. more about Nifty Private Bank

The Nifty PSU Bank Index is designed to reflect the performance of the public sector banks. more about Nifty PSU Bank

The Nifty Realty Index is designed to reflect the performance of real estate companies that are primarily engaged into construction of residential and commercial properties. more about Nifty Realty

The Nifty Consumer Durables Index is designed to reflect the performance of stocks belonging to Consumer Durables industry. The Nifty Consumer Durables Index comprises of maximum of 15 stocks that are listed on the National Stock Exchange. more about Nifty Consumer Durables

The Nifty Oil & Gas Index is designed to reflect the performance of the stocks belonging to Oil, Gas and Petroleum industry. The Nifty Oil & Gas Index comprises of maximum of 15 stocks that are listed on the National Stock Exchange. more about Nifty Oil and Gas

The Nifty MidSmall Financial Services index tracks the performance of midcap and small cap stocks belonging to financial services sector. Index includes upto 30 stocks. Stock weights are based on free-float market capitalization more about Nifty MidSmall Financial Services

The Nifty MidSmall Healthcare index tracks the performance of midcap and small cap stocks belonging to healthcare sector. Index includes upto 30 stocks. Stock weights are based on free-float market capitalization. more about Nifty MidSmall Healthcare

The Nifty MidSmall IT & Telecom index tracks the performance of midcap and small cap stocks belonging to information technology & telecommunication sector. Index includes upto 20 stocks. Stock weights are based on free-float market capitalization. more about Nifty MidSmall IT & Telecom

Leave a Reply

Your email address will not be published. Required fields are marked *